Founder and President
Dr. Weinberg is a Founder of ResQ Pharma and the inventor of LRT. He is currently a Professor of Anesthesiology at the
University of Illinois College of Medicine
at Chicago. He has authored over
100 peer-reviewed research articles.
Director of Regulatory Affairs
Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality assurance, clinical trials, and development strategies. He has led the clinical development of more than 100 products and 100 GCP, GLP, GMP, a
Director of Regulatory Affairs
Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality assurance, clinical trials, and development strategies. He has led the clinical development of more than 100 products and 100 GCP, GLP, GMP, and GACP audits in the North and South Americas, Europe, and Asia.
Director of Product Development
Dr. Bryant brings more than 25 years in R&D management. He is the Founder of Sagitta Biotherapeutics and Vice President of Technical Operations at Levo Therapeutics.
He is a specialist in all phases of
biologics development.
Clinical Affairs
Dr. Hubbard is the former Vice President of Clinical Research at Pfizer and member of FDA’s Pulmonary and Allergy Advisory Committee. He is on the Board of Northwestern University’s Biomedical IRB.
Chief Administrative Officer
and General Counsel
Mr. Schupp is an accomplished attorney with extensive experience as outside counsel, in-house counsel and senior business management, leading efforts to transform business practices to improve process efficiency, strengthen operations and drive business production.
Chief Operating Officer
Owner at Physician First Consultants, LLC with over 14 years of successful sales and business/product development experience.
LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA.
LipidRescue® is a proposed proprietary name that is subject to FDA approval.
Website designed by JDW
Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.
Powered by GoDaddy